AbbVie
ABBV
4,285 hedge funds and large institutions have $343B invested in AbbVie in 2026 Q3 according to their latest regulatory filings, with 216 funds opening new positions, 1,843 increasing their positions, 1,697 reducing their positions, and 99 closing their positions.
118% more first-time investments, than exits
New positions opened: 216 | Existing positions closed: 99
14% more call options, than puts
Call options by funds: $4.11B | Put options by funds: $3.62B
9% more repeat investments, than reductions
Existing positions increased: 1,843 | Existing positions reduced: 1,697
1% more funds holding
Funds holding: 4,263 → 4,285 (+22)
0% more funds holding in top 10
Funds holding in top 10: 201 → 201 (0)
1.93% less ownership
Funds ownership: 76.06% → 74.13% (-1.9%)
26% less capital inflows, than outflows
Capital inflows: $14.1B | Capital outflows: $19B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.45B |
| 2 |
UBS AM
Chicago,
Illinois
|
+$1.38B |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$1.32B |
| 4 |
Bank of New York Mellon
New York
|
+$557M |
| 5 |
Amundi
Paris,
France
|
+$431M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.21B |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$656M |
| 3 |
JP Morgan Chase
New York
|
-$648M |
| 4 |
Goldman Sachs
New York
|
-$493M |
| 5 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$487M |
ABBV Hedge Fund Activity: Q3 2026 in Review
4,285 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q3 2026, worth a combined $343B — up 1.6% from $338B a quarter earlier.
Buyers outnumbered sellers: 216 funds opened new ABBV positions and 99 closed out — a net gain of 117 holders — while 1,843 added to existing stakes and 1,697 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $1.45B. The largest seller was Royal Bank of Canada, cutting an estimated $2.21B.
- 4,285 institutional investors held AbbVie (ABBV) as of Q3 2026, up from 4,263 in Q2 2026.
- Funds reported $343B of AbbVie stock for Q3 2026, up 1.6% quarter-over-quarter.
- 216 funds opened new AbbVie positions in Q3 2026 and 99 closed out, a net change of +117 holders.
- The largest AbbVie buyer in Q3 2026 was Wellington Management Group, an estimated $1.45B added.
- The largest AbbVie seller in Q3 2026 was Royal Bank of Canada, an estimated $2.21B sold.
Based on aggregated 13F filings for Q3 2026.